Long-acting injectable version of the most popular HIV drug combination is possible
The European AIDS Conference revisits Warsaw
PrEP use in pregnancy doesn't raise the risk of adverse pregnancy or birth outcomes
Past infection and vaccination protects against severe mpox
US study confirms no increased risk of neural tube defects after taking dolutegravir in pregnancy
Another class of cancer drugs may contribute to curing HIV
Users of TAF in PrEP more likely to develop high blood pressure or need statins
Competing priorities impact HIV treatment adherence for South Africans with low incomes
Two-thirds of countries in Latin America and the Caribbean offer PrEP
